TRxADE HEALTH, Inc. (MEDS) Misses Q1 EPS by 5c

TRxADE HEALTH, Inc. (NASDAQ: MEDS) reported Q1 EPS of ($0.07), $0.05 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.75 million.

For earnings history and earnings-related data on TRxADE HEALTH, Inc. (MEDS) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions
• Cummins wins battery storage contract for U.S. data center project